FR2315272A1 - Procede de preparation de nouveaux 2-piperidinoalcoyl-1,4-benzodioxannes - Google Patents

Procede de preparation de nouveaux 2-piperidinoalcoyl-1,4-benzodioxannes

Info

Publication number
FR2315272A1
FR2315272A1 FR7618796A FR7618796A FR2315272A1 FR 2315272 A1 FR2315272 A1 FR 2315272A1 FR 7618796 A FR7618796 A FR 7618796A FR 7618796 A FR7618796 A FR 7618796A FR 2315272 A1 FR2315272 A1 FR 2315272A1
Authority
FR
France
Prior art keywords
piperidinoalcoyl
benzodioxannes
preparing new
preparing
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7618796A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Priority claimed from US05/760,493 external-priority patent/US4129655A/en
Publication of FR2315272A1 publication Critical patent/FR2315272A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR7618796A 1975-06-23 1976-06-21 Procede de preparation de nouveaux 2-piperidinoalcoyl-1,4-benzodioxannes Withdrawn FR2315272A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/589,118 US4039676A (en) 1975-06-23 1975-06-23 2-piperidinoalkyl-1,4-benzodioxans
US05/760,493 US4129655A (en) 1976-04-26 1977-01-19 Neuroleptic 2-piperidinoalkyl-1,4-benzodioxans

Publications (1)

Publication Number Publication Date
FR2315272A1 true FR2315272A1 (fr) 1977-01-21

Family

ID=27080452

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7618796A Withdrawn FR2315272A1 (fr) 1975-06-23 1976-06-21 Procede de preparation de nouveaux 2-piperidinoalcoyl-1,4-benzodioxannes

Country Status (10)

Country Link
US (3) US4039676A (fr)
JP (1) JPS523073A (fr)
AT (1) AT350569B (fr)
AU (1) AU502667B2 (fr)
BE (1) BE843241A (fr)
DE (1) DE2627616A1 (fr)
FR (1) FR2315272A1 (fr)
GB (1) GB1544647A (fr)
NL (1) NL7606856A (fr)
SE (1) SE7607152L (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014295A1 (fr) * 1979-02-05 1980-08-20 Bouchara, Emile Dr. Nouveaux dérivés du benzodioxanne, leur procédé de préparation et leurs applications en thérapeutique
EP0041410A1 (fr) * 1980-04-10 1981-12-09 SCIENCE UNION ET Cie SOCIETE FRANCAISE DE RECHERCHE MEDICALE Nouveaux éthers tricycliques, leurs procédés de préparation et leur utilisation comme médicament
FR2501687A1 (fr) * 1981-03-13 1982-09-17 Spofa Vereinigte Pharma Werke Derives basiques de composes tricycliques et procedes pour leur preparation
WO2023154310A1 (fr) * 2022-02-08 2023-08-17 Vertex Pharmaceuticals Incorporated Dérivés de 2-méthyl-4-phénylpipéridin-4-ol utilisés en tant qu'inhibiteurs de apol1 et leurs procédés d'utilisation
US11866446B2 (en) 2020-08-26 2024-01-09 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
US12060346B2 (en) 2018-12-17 2024-08-13 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2349331A1 (fr) * 1976-04-30 1977-11-25 Roussel Uclaf Nouveaux derives de 2,3 dihydro a/4-(3-indolyl) 1-piperidinyl/methyl 1,4-benzodioxin-2-methanol, un procede pour leur preparation et leur application comme medicaments
US4302469A (en) * 1980-09-10 1981-11-24 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
FR2530632A1 (fr) * 1982-07-26 1984-01-27 Bouchara Emile Nouveaux derives substitues du 2,5-diamino 1,4-diazole, leurs procedes de preparation et les compositions pharmaceutiques en renfermant
JPS59191037U (ja) * 1984-03-30 1984-12-18 斉藤　太都司 流動性廃棄物の連続焼却装置
US4569933A (en) * 1984-04-13 1986-02-11 Cornu Pierre Jean Antihypertensive substituted derivatives of 2,5-diamino 1,4-diazole
JPS614140U (ja) * 1985-05-17 1986-01-11 太都司 斉藤 流動性廃棄物の連続焼却装置
GB8526209D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical process
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
EP0429535A1 (fr) * 1988-08-16 1991-06-05 E.I. Du Pont De Nemours And Company Derives fongicides de benzodioxane amine
ATE121740T1 (de) * 1989-03-22 1995-05-15 Ciba Geigy Ag Neue benzothiopyranylamine.
FR2704857B1 (fr) * 1993-05-07 1995-06-23 Adir Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
CA2220649C (fr) 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag Derives de 4-hydroxy-piperidine
EP0846683B1 (fr) * 1996-12-03 2001-09-19 F. Hoffmann-La Roche Ag Dérivés de la 4-hydroxypipéridine
WO2002022582A2 (fr) * 2000-09-14 2002-03-21 Ortho-Mcneil Pharmaceutical, Inc. Nouvelles formes solides de sel de n-[2-[4-[2-(1-methylethoxy)phenyl]-1-piperazinyl]ethyl]-2-oxo-1-piperidineacetamide
US6656951B2 (en) * 2001-04-24 2003-12-02 Wyeth 8-aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-HT1A antagonists
TWI457122B (zh) 2007-07-20 2014-10-21 Orion Corp 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物
EP3233077A4 (fr) 2014-12-19 2018-08-08 The Broad Institute Inc. Ligands des récepteurs dopaminergiques d2
EP3233799B1 (fr) 2014-12-19 2021-05-19 The Broad Institute, Inc. Ligands du récepteur d2 de la dopamine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2056046A (en) * 1933-05-19 1936-09-29 Rhone Poulenc Sa Manufacture of bases derived from benz-dioxane
US2956058A (en) * 1957-08-19 1960-10-11 Lilly Co Eli Novel substituted piperidines and pyrrolidines
US3149108A (en) * 1961-10-30 1964-09-15 Geigy Chem Corp Preparation of derivatives of 1, 4-benzodioxan
BE632701A (fr) * 1962-05-22
BE636238A (fr) * 1962-08-20
JPS4311456Y1 (fr) * 1965-06-25 1968-05-18
JPS422708Y1 (fr) * 1965-07-25 1967-02-17
GB1148214A (en) * 1965-11-26 1969-04-10 Ward Blenkinsop & Co Ltd Heterocyclic guanidine derivatives
US3476760A (en) * 1967-03-06 1969-11-04 Smithkline Corp Substituted piperidinoalkylthianaphthenes and benzofurans
US3513239A (en) * 1967-03-15 1970-05-19 Smithkline Corp Pharmaceutical compositions containing 2-aminoalkyl coumaran derivatives and methods of treating depression therewith
BE755589A (fr) * 1969-09-03 1971-03-02 Janssen Pharmaceutica Nv Benzimidazoolcarbamaten

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014295A1 (fr) * 1979-02-05 1980-08-20 Bouchara, Emile Dr. Nouveaux dérivés du benzodioxanne, leur procédé de préparation et leurs applications en thérapeutique
EP0041410A1 (fr) * 1980-04-10 1981-12-09 SCIENCE UNION ET Cie SOCIETE FRANCAISE DE RECHERCHE MEDICALE Nouveaux éthers tricycliques, leurs procédés de préparation et leur utilisation comme médicament
US4459306A (en) * 1980-04-10 1984-07-10 Science Union Et Cie Tricyclic ethers, their process of preparation and their use as medicines
FR2501687A1 (fr) * 1981-03-13 1982-09-17 Spofa Vereinigte Pharma Werke Derives basiques de composes tricycliques et procedes pour leur preparation
US12060346B2 (en) 2018-12-17 2024-08-13 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
US11866446B2 (en) 2020-08-26 2024-01-09 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
WO2023154310A1 (fr) * 2022-02-08 2023-08-17 Vertex Pharmaceuticals Incorporated Dérivés de 2-méthyl-4-phénylpipéridin-4-ol utilisés en tant qu'inhibiteurs de apol1 et leurs procédés d'utilisation

Also Published As

Publication number Publication date
JPS523073A (en) 1977-01-11
DE2627616A1 (de) 1977-01-13
AU1513076A (en) 1978-01-05
SE7607152L (sv) 1976-12-24
US4140781A (en) 1979-02-20
AU502667B2 (en) 1979-08-02
GB1544647A (en) 1979-04-25
NL7606856A (nl) 1976-12-27
ATA453776A (de) 1978-11-15
US4039676A (en) 1977-08-02
BE843241A (fr) 1976-12-22
AT350569B (de) 1979-06-11
US4104396A (en) 1978-08-01

Similar Documents

Publication Publication Date Title
FR2315272A1 (fr) Procede de preparation de nouveaux 2-piperidinoalcoyl-1,4-benzodioxannes
FR2301505A1 (fr) Procede de preparation de 2,2-dimethylolalcanals
BE839347A (fr) Procede de preparation de nouvelles indolyalcoylpiperidines
FR2313357A1 (fr) Procede de preparation du 1,4-diaminoanthraquinone-2,3-dinitrile
FR2302379A1 (fr) Procede de preparation de
BE842940A (fr) Procede de preparation d'oxaphospholannes-1,2,
BE839004A (fr) Procede de preparation de 4-oxo-hexahydropyrazino-isoquinoleine
BE847305A (fr) Procede de preparation de trichloromethyl-trifluormethylbenzenes,
FR2325656A1 (fr) Procede de preparation de chlorophosphites
BE847214A (fr) Procede de preparation de trimethyldroquinone,
FR2325629A1 (fr) Procede de preparation de coenzymes q
FR2333805A1 (fr) Procede de preparation de n,n'-bis-trimethylsilyluree
PT65338B (fr) Procede de preparation de nouveaux derives de 2-benzopiranone
FR2310998A1 (fr) Procede de preparation de la 2,5-dimethoxy-4-chloraniline
FR2298554A1 (fr) Procede de preparation de thymidine-phosphorylase, et preparation stabilisee obtenue
BE847542A (fr) Procede de preparation de phosphorodihalogenodithioates de s-alkyle,
BE843910A (fr) Procede de preparation de 2,5-dioxo-1-oxa-2-phospholanes
BE848318A (fr) Procede de preparation de mousses formo-phenoliques,
FR2305432A1 (fr) Procede de preparation de 3,5-dialcoyl-4-mercapto-phenol
BE837753A (fr) Procede de preparation de sulfonylurees
FR2309516A1 (fr) Procede de preparation du n-acetoacetyl-2,5-dimethoxy-4-chloranilide
FR2312518A1 (fr) Procede de preparation de polyurethannes cellulaires
BE840423A (fr) Procede de preparation de supports de magnetogramme
BE843500A (fr) Procede de preparation d'oxaphospholannes-1,2,
FR2317297A1 (fr) Procede de preparation de la d,l pantolactone

Legal Events

Date Code Title Description
ST Notification of lapse